Figure 2.
Suggestions for treatment of patients with marginal zone B-cell lymphoma (MZL).
Abbreviations: HCV, hepatitis C virus; IFN, interferon; LDH, lactate dehydrogenase; R-CHOP, rituximab, vincristine, doxorubicin, cyclophosphamide, predisolone; R-FC, rituximab, fludarabine, cyclophosphamide